Question 1

Does Goldman Sachs own JBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs holds 735,224 shares of JBIO (Jade Biosciences), worth $16.3M.

Question 2

How many shares of JBIO does Goldman Sachs own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs holds 735,224 shares of JBIO (Jade Biosciences).

Question 3

What is Goldman Sachs' JBIO position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs' JBIO position is worth $16.3M.

Question 4

Is Goldman Sachs buying or selling JBIO?

Accepted Answer

In Q2 2026, Goldman Sachs increased its JBIO position from 153,037 to 735,224 shares.

Question 5

When did Goldman Sachs first buy JBIO?

Accepted Answer

Goldman Sachs first reported JBIO in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	735,224	+380.4%	$16.3M	0.0%	$22.22	45
2026-Q1	Increased	153,037	+134.2%	$2.2M	0.0%	$13.91	42
2025-Q4	Decreased	65,340	-59.8%	$1M	0.0%	$15.56	0
2025-Q3	New	162,711	-	$1.4M	0.0%	$8.62	35

JBIO4 quarters

JBIO
4 quarters